KAM
NXTC icon

Krensavage Asset Management’s NextCure NXTC Stock Holding History

Krensavage Asset Management’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,608
Closed -$86K – 14
2022
Q3 		$86K Buy
2,608
+25
+1% +$1.27K 0.03% 14
2022
Q2 		$146K Buy
2,583
+34
+1% +$1.78K 0.05% 13
2022
Q1 		$149K Sell
2,549
-37
-1% -$2.31K 0.05% 12
2021
Q4 		$186K Buy
2,586
+9
+0.3% +$753 0.06% 10
2021
Q3 		$208K Sell
2,577
-36
-1% -$3.16K 0.07% 13
2021
Q2 		$252K Buy
2,613
+63
+2% +$6.45K 0.09% 13
2021
Q1 		$306K Buy
2,550
+26
+1% +$3.77K 0.11% 12
2020
Q4 		$330K Buy
+2,524
New +$326K 0.1% 12

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Krensavage Asset Management's NXTC Position: Q4 2022 in Review

Krensavage Asset Management sold out of NextCure (NXTC) in Q4 2022, closing a stake of 2,608 shares — an estimated $86K sold.

Krensavage Asset Management first reported a position in NXTC in Q4 2020 and held it in 8 quarters. The position peaked at $330K in Q4 2020. 45 funds tracked by Wall St. Rank hold NXTC as of Q4 2022.

  • Krensavage Asset Management reported no remaining NextCure position as of Q4 2022 after selling out during the quarter.
  • Krensavage Asset Management sold 2,608 NextCure shares in Q4 2022, an estimated $86K.
  • Krensavage Asset Management first reported a position in NextCure in Q4 2020 and held it in 8 quarters.
  • Krensavage Asset Management's NextCure position peaked at $330K in Q4 2020.
  • 45 funds tracked by Wall St. Rank held NextCure as of Q4 2022.

Based on Krensavage Asset Management's 13F filing for Q4 2022, filed 15 Feb 2023.